The Translational Synthetic Biology group is interested in learning from biological systems to create new paradigms in science and medicine. The group, led by Marc Güell, aims to leverage synthetic biology and gene editing to generate technologies with therapeutic potential. They have lines of research in new natural product evolution, microbiome engineering, and precise tools for gene therapy.

Research group website